Preclinical toxicology studies with tobramycin.
D000014:Abnormalities, Drug-Induced; D000410:Alanine Transaminase / Q000097:blood; D000606:Amino Sugars / Q000097:blood / Q000494:pharmacology / Q000633:toxicity; D000818:Animals; D000900:Anti-Bacterial Agents / Q000097:blood / Q000494:pharmacology / Q000633:toxicity*; D001794:Blood Pressure / Q000187:drug effects; D002415:Cats; D004285:Dogs; D005260:Female; D005839:Gentamicins / Q000633:toxicity; D006027:Glycosides / Q000097:blood / Q000494:pharmacology / Q000633:toxicity; D006168:Guinea Pigs; D007668:Kidney / Q000473:pathology; D008297:Male; D051379:Mice; D008813:Mice, Inbred ICR; D009355:Neomycin / Q000633:toxicity; D009469:Neuromuscular Junction / Q000187:drug effects; D011247:Pregnancy; D011817:Rabbits; D051381:Rats; D013997:Time Factors
D000606:Amino Sugars; D000900:Anti-Bacterial Agents; D005839:Gentamicins; D006027:Glycosides; D000410:Alanine Transaminase; D009355:Neomycin